Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    03034135
Previous Study | Return to List | Next Study

Safety, Tolerability and Efficacy of Disulfiram and Copper Gluconate in Recurrent Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03034135
Recruitment Status : Completed
First Posted : January 27, 2017
Last Update Posted : August 7, 2019
Sponsor:
Information provided by (Responsible Party):
Cantex Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 10, 2018
Actual Study Completion Date : July 10, 2018
Certification/Extension First Submitted : July 23, 2019